Merck Shares Outstanding 2006-2020 | MRK

Merck shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merck shares outstanding for the quarter ending June 30, 2020 were 2.536B, a 2.01% decline year-over-year.
  • Merck 2019 shares outstanding were 2.58B, a 3.7% decline from 2018.
  • Merck 2018 shares outstanding were 2.679B, a 2.51% decline from 2017.
  • Merck 2017 shares outstanding were 2.748B, a 1.4% decline from 2016.
Merck Annual Shares Outstanding
(Millions of Shares)
2019 2,580
2018 2,679
2017 2,748
2016 2,787
2015 2,841
2014 2,928
2013 2,996
2012 3,076
2011 3,094
2010 3,120
2009 2,273
2008 2,143
2007 2,190
2006 2,188
2005 2,200
Merck Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 2,536
2020-03-31 2,547
2019-12-31 2,580
2019-09-30 2,572
2019-06-30 2,588
2019-03-31 2,603
2018-12-31 2,679
2018-09-30 2,678
2018-06-30 2,696
2018-03-31 2,710
2017-12-31 2,748
2017-09-30 2,727
2017-06-30 2,752
2017-03-31 2,766
2016-12-31 2,787
2016-09-30 2,786
2016-06-30 2,789
2016-03-31 2,795
2015-12-31 2,841
2015-09-30 2,836
2015-06-30 2,850
2015-03-31 2,865
2014-12-31 2,928
2014-09-30 2,911
2014-06-30 2,949
2014-03-31 2,971
2013-12-31 2,996
2013-09-30 2,960
2013-06-30 3,010
2013-03-31 3,053
2012-12-31 3,076
2012-09-30 3,079
2012-06-30 3,072
2012-03-31 3,074
2011-12-31 3,094
2011-09-30 3,091
2011-06-30 3,110
2011-03-31 3,104
2010-12-31 3,120
2010-09-30 3,102
2010-06-30 3,125
2010-03-31 3,141
2009-12-31 2,273
2009-09-30 2,114
2009-06-30 2,110
2009-03-31 2,109
2008-12-31 2,143
2008-09-30 2,133
2008-06-30 2,152
2008-03-31 2,172
2007-12-31 2,190
2007-09-30 2,193
2007-06-30 2,189
2007-03-31 2,180
2006-12-31 2,188
2006-09-30 2,186
2006-06-30 2,188
2006-03-31 2,191
2005-12-31 2,200
2005-09-30 2,197
2005-06-30 2,206
2005-03-31 2,210
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $217.034B $46.840B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.765B 18.72
Roche Holding AG (RHHBY) Switzerland $320.783B 0.00
Novartis AG (NVS) Switzerland $208.134B 16.18
Pfizer (PFE) United States $203.549B 12.72
Novo Nordisk (NVO) Denmark $163.517B 26.60
AbbVie (ABBV) United States $159.029B 9.69
AstraZeneca (AZN) United Kingdom $148.146B 28.80
Eli Lilly (LLY) United States $147.459B 22.51
Sanofi (SNY) $131.317B 15.61
GlaxoSmithKline (GSK) United Kingdom $98.485B 12.91
Bayer (BAYRY) Germany $63.190B 9.11
H Lundbeck (HLUYY) Denmark $6.681B 0.00
Innoviva (INVA) United States $1.173B 5.61